Almost 20 years ago, there were skeptics when Ottawa stem cell transplant physician Dr. Harold Atkins and his colleague Dr. Mark Freedman first proposed using stem cells to “reprogram” the immune system to stop the progress of multiple sclerosis.
In June 2016, a paper on 24 patients published in the prestigious medical journal The Lancet concluded that the treatment halted damage to the brain caused by the immune system, stopping relapses for 70 per cent of patients. The disabilities of many patients stabilized. Some even recovered lost abilities.
No comments:
Post a Comment